- Investing Ideas
- Hong Kong Big Pharma, Big Dividends
Hong Kong Big Pharma, Big Dividends
Results
5
Large pharmaceutical stocks to buy with strong dividend features.
5 companies
CSPC Pharmaceutical Group
Market Cap: HK$114.2b
An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.
1093
HK$9.54
7D
-6.9%
1Y
91.2%
Sino Biopharmaceutical
Market Cap: HK$114.2b
An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.
1177
HK$6.15
7D
-5.8%
1Y
78.8%
China Medical System Holdings
Market Cap: HK$36.8b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$14.63
7D
-4.6%
1Y
75.0%
China Resources Pharmaceutical Group
Market Cap: HK$29.4b
An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
3320
HK$4.60
7D
0.2%
1Y
-16.2%
Grand Pharmaceutical Group
Market Cap: HK$27.6b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
512
HK$7.75
7D
2.6%
1Y
49.3%